Leonard Pattenden | Head Of Biotherapeutics Development And Drug Supply Biotherapeutics Development Unit
Cancer Research UK

Leonard Pattenden, Head Of Biotherapeutics Development And Drug Supply Biotherapeutics Development Unit, Cancer Research UK

Currently the Head of Cancer Research UK GMP Biotherapeutics Development Unit. Leonard Pattenden's pharmaceutical experience is primarily in the development of a range of biomolecules such as therapeutic blood factors and monoclonal antibodies, but he also has a track record in viral vector and virus-like molecule design, production, purification and manipulation. His current interests around lentiviral vectors are the application of synthetic biology and smaller-scale GMP continuous manufacturing strategies (scale-out) as an approach to meet clinical demand.

Appearances:



Conference Day 1 - Tuesday 31st March 2020 @ 17:00

Lentiviral vector production for advanced therapies

last published: 06/Dec/19 09:35 GMT

back to speakers